This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
HBSP (USA)
-
Merck: La administración de Vioxx (D)
Simons, Robert L.; Rosenberg, Kathryn; Kindred, NatalieCase HBS-111S05Knowledge and CommunicationStarting at €5.74
-
Merck: La administración de Vioxx (G)
Simons, Robert L.; Kindred, NatalieCase HBS-111S08Knowledge and CommunicationStarting at €8.20
-
Making the Numbers (Spanish version)
Simons, Robert L.; Packard, JenniferCase HBS-118S02Strategy1) founding, 2) growth, 3) push to profitability, 4) relocation process, and 5) takeover by new management. At each stage, students must confront tensions in balancing profit, growth and control. Difficulties encountered in the business are due to management's attempts to design and use formal control systems to achieve profit and performance goals.Starting at €8.20
-
ATH Technologies (A): cumpliendo los objetivos
Simons, Robert L.; Packard, JenniferCase HBS-118S03StrategyUn ejercicio que lleva a los estudiantes a través de cinco etapas de crecimiento empresarial en una puesta en marcha en la industria de dispositivos médicos: 1) fundación, 2) el crecimiento, 3) empuje a la rentabilidad, el proceso de reorientación 4) y 5) toma de control por la nueva administración. En cada etapa, los estudiantes deben hacer frente a las tensiones en el equilibrio de beneficios, el crecimiento y el control. Las dificultades encon...Starting at €8.20
-
Managing Risk in the New World
Kaplan, Robert S.; Mikes, Anette; Simons, Robert L.; Tufano, Peter; Hofmann, Michael; Champion, DavidArticle HBS-R0910E-EFive experts gathered recently to discuss the future of enterprise risk management: Kaplan, the Baker Foundation Professor at Harvard Business School, who with his colleague David Norton developed the balanced scorecard; Mikes, an assistant professor at HBS who studies the evolution of risk management and the role of the chief risk officer; Simons, the Charles M. Williams Professor of Business Administration at HBS; Tufano, the Sylvan C . Coleman...Starting at €8.20
-
Aqua Bounty
White, Lucy; Burn-Murdoch, StephenCase HBS-213047-EFinanceValuation of a pre-revenue biotech company at IPO using probability trees and real option techniques. Company is based in Massachusetts and lists in London on AIM. Products are genetically-modified fast-growing salmon for fish farmers and disease-preventiStarting at €8.20
-
The TELUS Share Conversion Proposal
White, Lucy; Esty, Benjamin C.; Mazzanti, LisaCase HBS-214001-EFinanceOn February 21, 2013, TELUS announced a proposal to convert the firm's non-voting shares into voting shares on a one-to-one basis, thereby eliminating the firm's dual class structure. Shareholders were scheduled to vote on the proposal at the firm's annual general meeting (AGM) on May 9, 2013. Despite strong support from management, the board, two proxy advisory firms, and several large shareholders, the proposal was opposed by Mason Capital Mana...Starting at €8.20
-
Barclays Bank and Contingent Capital Notes, 2012
White, Lucy; Kim, TrentCase HBS-214063-EFinanceIn 2012, regulatory changes following the financial crisis mean that Barclays Bank is faced with the need to raise large amounts of capital in order to comply with increased capital requirements, tightening rules as to the "quality of capital," and increased risk weights for its capital markets assets. The bank is contemplating offering contingent capital bonds, which would act like debt during "normal times" but would convert to create capital s...Starting at €8.20
-
Empty Voting: Corporate Governance and Control in the Age of Derivatives, Module Note for Instructors
White, LucyTeaching Note HBS-214080-EFinanceStarting at €0.00
-
Barclays Bank, 2008
White, Lucy; Burn-Murdoch, Stephen; Lenhardt, JeromeCase HBS-215027-EFinanceIn the midst of the financial crisis, Barclays (the world's 4th largest bank by assets) is forced by UK regulators to raise more capital. Should it take up the UK government's offer to invest, or take funding from investors from the Middle East? Students may price the two deals to determine which is more expensive, and must decide whether avoiding the constraints of government ownership is worth the extra cost.Starting at €8.20